Alexandria Real Estate Equities, Inc. - Nov 2, 2023 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
10%+ Owner
Signature
ALEXANDRIA EQUITIES NO. 7, LLC By: ARE-Special Services, LLC, managing member By: ALEXANDRIA REAL ESTATE EQUITIES, L.P., managing member By: ARE-QRS CORP., general partner By: /s/ Marc E. Binda, Chief Financial Officer and Treasurer
Stock symbol
APLT
Transactions as of
Nov 2, 2023
Transactions value $
-$572,204
Form type
4
Date filed
11/6/2023, 04:56 PM
Previous filing
Nov 2, 2023
Next filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Sale -$241K -104K -1.78% $2.32 5.72M Nov 2, 2023 By subsidiary F1, F2
transaction APLT Common Stock Sale -$331K -143K -2.51% $2.31 5.58M Nov 3, 2023 By subsidiary F2, F3
holding APLT Common Stock 779K Nov 2, 2023 By subsidiary F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $2.30 to $2.39. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC ("AE7"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc.
F3 The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $2.25 to $2.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 These securities are held directly by AE7, a wholly owned subsidiary of Alexandria Real Estate Equities, Inc.